Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma (POLARIS)

This study has been completed.
Sponsor:
Collaborator:
Centro de Immunologia Molecular, Cuba
Information provided by (Responsible Party):
Eurofarma Laboratorios S.A.
ClinicalTrials.gov Identifier:
NCT01145170
First received: June 14, 2010
Last updated: July 24, 2015
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)